A new approach to the continuous monitoring of transvenous lead extraction using transesophageal echocardiography-Analysis of 936 procedures.
continuous echocardiographic monitoring
transesophageal echocardiography
transvenous lead extraction
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
07
01
2020
revised:
12
12
2019
accepted:
18
02
2020
pubmed:
11
3
2020
medline:
24
6
2021
entrez:
11
3
2020
Statut:
ppublish
Résumé
The usefulness of transesophageal echocardiographic (TEE) monitoring for transvenous lead extraction (TLE) procedures is still controversial. The purpose of the current study was to present new TEE values in detecting invisible events in fluoroscopy and preventing the development of dangerous complications. From 2015 to 2019, a total of 1026 procedures were performed in single TLE center. In total, 1108 leads had been extracted with a mean lead dwell time of 115.8 ± 77.6 months. Continuous TEE was used in 936 patients with a mean age of 67.1 ± 14.4 years. Preprocedure examination revealed looped leads in 181 (19.3%) patients, dry cardiac perforation in 151 (16.1%), lead-to-lead adhesion in 172 (18.4%), lead adhesion to the myocardium in 317 (33.9%), and vegetations in 119 (12.7%) patients. Intra-procedural TEE demonstrated pulling on the atrial wall, ventricular wall, or tricuspid valve in 380 (40.5%), 235 (25.1%), and 78 (8.3%) patients, respectively. Acute tamponade requiring sternotomy occurred in 11 (1.1%) patients. Migration of vegetation or connective tissue fragments were seen in 69 (7.3%) and 111 (11.8%) patients, respectively. After procedure, TEE was helpful in navigating an implantation, a new lead in 97 (10.3%) patients, and removing the remnants of lead/silicone insulation in 50 (5.3%) patients. Real time transesophageal echocardiography for the guidance of transvenous lead extraction informs the operator about the danger of manipulations close to delicate cardiac structures and whether immediate modification to the plan of lead removal is necessary in order to prevent the occurrence of unwanted events.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
601-611Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Radegran K. The early history of cardiac surgery in Stockholm. J Card Surg. 2003;18:564-572.
Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: heart rhythm society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart association (AHA). Heart Rhythm. 2009;6:1085-1104.
Deharo JC, Bongiorni MG, Rozkovec A, et al. Pathways for training and accreditation for transvenous lead extraction: European heart rhythm association position paper. Europace. 2012;14:124-134.
Endo Y, O'Mara JE, Weiner S, et al. Clinical utility of intraprocedural transesophageal echocardiography during transvenous lead extraction. J Am Soc Echocardiogr. 2008;21:861-867.
Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the LExICon study. J Am Coll Cardiol. 2010;55:579-586.
Roux JF, Page P, Dubuc M, et al. Laser lead extraction: predictors of success and complications. Pacing Clin Electrophysiol. 2007;30:214-220.
Jones SO, Eckart RE, Albert CM, Epstein LM. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm. 2008;5:520-525.
Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503-e551.
Bongiorni MG, Burri H, Deharo JC, et al. EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018;2018:1-11.
Rizzello V, Dello Russo A, Casella M, Biddau R. Residual fibrous tissue floating in the right atrium after percutaneous pacemaker lead extraction: an unusual complication early detected by intracardiac echocardiography. Int J Cardiol. 2008;127:e67-e68.
Tomaszewski A, Kutarski A, Tomaszewski M. Łącznotkankowe pozostałości po usuniętych elektrodach. Kardiologia Polska. 2011;69:619-620.
Narducci ML, Di Monaco A, Pelargonio G, et al. Presence of "ghosts" and mortality after transvenous lead extraction. Europace. 2017;1(19):432-440.
Alizadehasl A, Sarrafi Rad N, Pourafkari L, Haghjoo M. Persistence of a pacemaker lead-like "ghost" 6 months after lead extraction. Echocardiography. 2019;36:201-203.
Poterała M, Kutarski A, Brzozowski W, Tomaszewski M, Gromadziński L, Tomaszewski A. Echocardiographic assessment of residuals after transvenous intracardiac lead extraction. Int J Cardiovasc Imaging. 2019;29:1-8.
Cahalan MK, Stewart W, Pearlman A, et al. American society of echocardiography and society of cardiovascular anesthesiologists task force guidelines for training in perioperative echocardiography. J Am Soc Echocardiogr. 2002;15:647-652.
Love CJ. Transesophageal echocardiography monitoring during lead extraction procedures. JACC Clin Electrophysiol. 2015;1:449-450.
Hilberath JN, Burrage PS, Shernan SK, et al. Rescue transoesophageal echocardiography for refractory haemodynamic instability during transvenous lead extraction. Eur Heart J Cardiovasc Imaging. 2014;15:926-932.
Regoli F, Caputo M, Conte G, et al. Clinical utility of routine use of continuous transesophageal echocardiography monitoring during transvenous lead extraction procedure. Heart Rhythm. 2015;12:313-320.
Swanton BJ, Keane D, Vlahakes GJ, Streckenbach SC. Intraoperative transesophageal echocardiography in the early detection of acute tamponade after laser extraction of a defibrillator lead. Anesth Analg. 2003;97:654-665.
Brunner MP, Cronin EM, Duarte VE, et al. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm. 2014;11:799-805.
Bongiorni MG, Soldati E, Zucchelli G, et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J. 2008;29:2886-2893.
Franceschi F, Thuny F, Giorgi R, et al. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol. 2009;53:2168-2174.
Park SJ, Gentry JL, Varma N, et al. Transvenous extraction of pacemaker and defibrillator leads and the risk of tricuspid valve regurgitation. JACC Clin Electrophysiol. 2018;4:1421-1428.
Glover BM, Watkins S, Mariani JA, et al. Prevalence of tricuspid regurgitation and pericardial effusions following pacemaker and defibrillator lead extraction. Int J Cardiol. 2010;145:593-594.
Roeffel S, Bracke F, Meijer A, et al. Transesophageal echocardiographic evaluation of tricuspid valve regurgitation during pacemaker and implantable cardioverter defibrillator lead extraction. Pacing Clin Electrophysiol. 2003;25:1583-1586.
Coffey JO, Sager SJ, Gangireddy S, Levine A, Viles-Gonzalez JF, Fischer A. The impact of transvenous lead extraction on tricuspid valve function. Pacing Clin Electrophysiol. 2014;37:19-24.
Strachinaru M, Kievit CM, Yap SC, Hirsch A, Geleijnse ML, Szili-Torok T. Multiplane/3D transesophageal echocardiography monitoring to improve the safety and outcome of complex transvenous lead extractions. Echocardiography. 2019;36:980-986.
Oestreich BA, Ahlgren B, Seres T, et al. Use of transesophageal echocardiography to improve the safety of transvenous lead extraction. JACC Clin Electrophysiol. 2015;1:442-448.